Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
222.4 USD | +1.17% | +1.17% | +12.87% |
Financials (USD)
Sales 2024 * | 2.72B | Sales 2025 * | 3.04B | Capitalization | 12.69B |
---|---|---|---|---|---|
Net income 2024 * | 449M | Net income 2025 * | 548M | EV / Sales 2024 * | 4.12 x |
Net cash position 2024 * | 1.46B | Net cash position 2025 * | 2.25B | EV / Sales 2025 * | 3.43 x |
P/E ratio 2024 * |
29.1
x | P/E ratio 2025 * |
22.6
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
1 day | +1.17% | ||
1 week | +1.17% | ||
Current month | -2.47% | ||
1 month | -3.74% | ||
3 months | -1.28% | ||
6 months | +14.03% | ||
Current year | +12.87% |
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 14-04-29 |
Darren Rushworth
PSD | President | 56 | 16-12-31 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 16-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 13-07-31 |
David Kostman
CHM | Chairman | 59 | 00-12-31 |
Dan Falk
BRD | Director/Board Member | 79 | 00-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.75% | 3,123B | |
+10.06% | 86.45B | |
+6.04% | 78.6B | |
-14.66% | 53.98B | |
+26.73% | 48.46B | |
-24.44% | 46.78B | |
+31.74% | 46.36B | |
+82.12% | 42.36B | |
-8.15% | 25.22B |
- Stock Market
- Equities
- NICE Stock
- NCSYF Stock